Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-17-013191
Filing Date
2017-12-13
Accepted
2017-12-13 16:37:23
Documents
66
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2017_citiuspharma.htm 10-K 912781
2 SUBSIDIARIES f10k2017ex21_citiuspharma.htm EX-21 1740
3 CERTIFICATION f10k2017ex31-1_citiuspharma.htm EX-31.1 10750
4 CERTIFICATION f10k2017ex31-2_citiuspharma.htm EX-31.2 10938
5 CERTIFICATION f10k2017ex32-1_citiuspharma.htm EX-32.1 5012
6 CERTIFICATION f10k2017ex32-2_citiuspharma.htm EX-32.2 4943
7 GRAPHIC image_001.jpg GRAPHIC 47784
8 GRAPHIC image_002.jpg GRAPHIC 10199
  Complete submission text file 0001213900-17-013191.txt   4697988

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE ctxr-20170930.xml EX-101.INS 714551
10 XBRL SCHEMA FILE ctxr-20170930.xsd EX-101.SCH 56098
11 XBRL CALCULATION FILE ctxr-20170930_cal.xml EX-101.CAL 36614
12 XBRL DEFINITION FILE ctxr-20170930_def.xml EX-101.DEF 171549
13 XBRL LABEL FILE ctxr-20170930_lab.xml EX-101.LAB 438791
14 XBRL PRESENTATION FILE ctxr-20170930_pre.xml EX-101.PRE 308459
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38174 | Film No.: 171254238
SIC: 2834 Pharmaceutical Preparations